- 2025/6/21Pimonidazole hydrochloride,盐酸哌莫硝唑,70132-51-3,99.94%
- 2025/6/21CCR6 antagonist 1,588674-64-0,99.30%
- 2025/6/21达昔单抗,Daclizumab,152923-56-3,≥99.0%
- 2025/6/21FIN56,1083162-61-1,98.03%
- 2025/6/21Eganelisib,1693758-51-8,99.68%
- 2025/6/21Indisulam,165668-41-7,99.80%
- 2025/6/21DL-β-Hydroxybutyryl coenzyme A lithium,DL-β-羟基丁酰辅酶A锂盐,103404-51-9,98.00%
- 2025/6/21IMT1B,2304621-06-3,99.45%
- 2025/6/2115-Deoxy-Δ-12,14-prostaglandin J2,87893-55-8,≥99.0%
- 2025/6/21A1874,2064292-12-0,99.70%
- 2025/6/21MeTC7,1817841-22-7,98.50%
- 2025/6/20铁死亡机制全解析:五大核心通路与MCE化合物库 | MCE
- 2025/6/20GNE-987,2417371-71-0,99.91%
- 2025/6/20D-Mannitol,D-甘露醇,69-65-8,99.93%
- 2025/6/20PD146176,4079-26-9,99.16%
- 2025/6/20ZM241385,139180-30-6,99.45%
- 2025/6/20Tamoxifen (Standard),他莫昔芬(标准品),10540-29-1,99.76%
- 2025/6/20β-Muricholic acid,2393-59-1,99.92%
- 2025/6/20索洛奇单抗,Sonelokimab,1414386-05-2,99.81%
- 2025/6/20戈莱恩尼单抗,Galegenimab,2403683-24-7,99.91%
- 2025/6/20Ibrexafungerp citrate,1965291-08-0,99.38%
- 2025/6/20ODN D-SL01 sodium,99.94%
- 2025/6/205-Azido-PEG4-SS-UTP tristriethylamine,99.09%
- 2025/6/20γ-Aminobutyric acid-13C4,γ-氨基丁酸 13C4,≥99.0%
- 2025/6/20Mitapivat,1260075-17-9,99.84%
- 2025/6/20n-Octyl β-D-glucopyranoside,正辛基β-D-吡喃葡萄糖苷,29836-26-8,≥98.0%